Multicell Technologies Inc (MCET) financial statements (2021 and earlier)

Company profile

Business Address 68 CUMBERLAND STREET, SUITE 301
WOONSOCKET, RI 02865
State of Incorp. DE
Fiscal Year End November 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

5/31/2015
Q2
2/28/2015
Q1
11/30/2014
Q4
8/31/2014
Q3
5/31/2014
Q2
2/28/2014
Q1
11/30/2013
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Other current assets0000000
Total current assets:0000000
Noncurrent Assets
Property, plant and equipment0(0) (0)(0)(0) 
Other noncurrent assets0000000
Other undisclosed noncurrent assets 0 000 
Total noncurrent assets:0000000
TOTAL ASSETS:0000000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1111111
Other undisclosed accounts payable and accrued liabilities1111111
Debt00    0
Due to related parties0000000
Deferred revenue and credits0000000
Other undisclosed current liabilities0000 00
Total current liabilities:1111111
Noncurrent Liabilities
Long-term debt and lease obligation  0000 
Long-term debt, excluding current maturities  0000 
Liabilities, other than long-term debt0000000
Deferred revenue and credits0000000
Derivative instruments and hedges, liabilities0000000
Total noncurrent liabilities:0000010
Total liabilities:2222222
Stockholders' equity
Stockholders' equity attributable to parent, including:(0)(0)(0)(0)(0)(0)(0)
Common stock50494642393226
Additional paid in capital   141117
Accumulated deficit(51)(49)(46)(44)(44)(44)(43)
Other undisclosed stockholders' equity attributable to parent0000000
Stockholders' equity attributable to noncontrolling interest(1)(1)(1)(1)(1)(1)(1)
Total stockholders' equity:(1)(2)(2)(2)(2)(2)(2)
TOTAL LIABILITIES AND EQUITY:0000000

Income statement (P&L) ($ in millions)

5/31/2015
Q2
2/28/2015
Q1
11/30/2014
Q4
8/31/2014
Q3
5/31/2014
Q2
2/28/2014
Q1
11/30/2013
Q4
Revenue, net1000000
Gross profit:1000000
Operating expenses(0)(0)(0)0(0)(0)(0)
Operating income (loss):0(0)(0)0(0)(0)(0)
Nonoperating income (expense)(0)000(0)(0)0
Investment income, nonoperating(0)000(0)(0)0
Interest and debt expense(0)(0)0(0)(0)(0)(0)
Income (loss) before gain (loss) on sale of properties:0(0)00(0)(0)(0)
Other undisclosed net income (loss)00(0)00  
Net income (loss):0(0)(0)0(0)(0)(0)
Net income (loss) attributable to noncontrolling interest(0)000000
Net income (loss) available to common stockholders, basic:0(0)(0)0(0)(0)(0)
Interest on convertible debt0  0   
Net income (loss) available to common stockholders, diluted:0(0)(0)0(0)(0)(0)

Comprehensive Income ($ in millions)

5/31/2015
Q2
2/28/2015
Q1
11/30/2014
Q4
8/31/2014
Q3
5/31/2014
Q2
2/28/2014
Q1
11/30/2013
Q4
Net income (loss):0(0)(0)0(0)(0)(0)
Comprehensive income (loss):0(0)(0)0(0)(0)(0)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)000(0)(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:0(0)(0)0(0)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: